Konstantinos Alevizopoulos
Chief Executive Officer at APIM Therapeutics AS
Profile
Konstantinos Alevizopoulos is the founder of CASiGEN Pharma Ltd., Hellenic Biotechnology Cluster, Zestagen AG.
He is currently the Chief Executive Officer at APIM Therapeutics AS since 2014 and a Partner at Ventac Partners GmbH since 2007.
Previously, he held positions as the Chief Executive Officer at Medexis Biotech SA, Chief Scientific Officer at Gerolymatos International SA, Head of Preclinical Research & Development at Biovista, Inc., and Head of Research & Development at Apotech SA. He holds a doctorate degree from the University of Lausanne and an undergraduate degree from the National & Kapodistrian University of Athens.
Konstantinos Alevizopoulos active positions
| Companies | Position | Start |
|---|---|---|
APIM Therapeutics AS
 APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Chief Executive Officer | 25/05/2010 |
Ventac Partners GmbH
 Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Corporate Officer/Principal | 31/07/2007 |
Former positions of Konstantinos Alevizopoulos
| Companies | Position | End |
|---|---|---|
Biovista, Inc.
 Biovista, Inc. Internet Software/ServicesTechnology Services Biovista, Inc. operates as an artificial intelligence platform to develop pipeline drugs. The firm offers drug repositioning, personalized medicine, drug de risking, clinical hold and pipeline services. The company was founded by Aris Persidis and Andreas Persidis and is headquartered in Charlottesville, VA. | Corporate Officer/Principal | - |
| Apotech SA | Chief Tech/Sci/R&D Officer | - |
| Medexis Biotech SA | Chief Executive Officer | - |
Gerolymatos International SA
 Gerolymatos International SA Pharmaceuticals: MajorHealth Technology Part of Alapis Holding Industrial & Commercial SA, Gerolymatos International SA is a Greek company that manufactures and distributes pharmaceutical products. The company is based in Kryoneri, Greece. | Chief Tech/Sci/R&D Officer | - |
| Zestagen AG | Founder | - |
Training of Konstantinos Alevizopoulos
| University of Lausanne | Doctorate Degree |
| National & Kapodistrian University of Athens | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Ventac Partners GmbH
Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Commercial Services |
| Medexis Biotech SA | |
Gerolymatos International SA
Gerolymatos International SA Pharmaceuticals: MajorHealth Technology Part of Alapis Holding Industrial & Commercial SA, Gerolymatos International SA is a Greek company that manufactures and distributes pharmaceutical products. The company is based in Kryoneri, Greece. | Health Technology |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Health Technology |
| CASiGEN Pharma Ltd. | |
Biovista, Inc.
Biovista, Inc. Internet Software/ServicesTechnology Services Biovista, Inc. operates as an artificial intelligence platform to develop pipeline drugs. The firm offers drug repositioning, personalized medicine, drug de risking, clinical hold and pipeline services. The company was founded by Aris Persidis and Andreas Persidis and is headquartered in Charlottesville, VA. | Technology Services |
| Hellenic Biotechnology Cluster | |
| Zestagen AG | |
| Apotech SA |
- Stock Market
- Insiders
- Konstantinos Alevizopoulos